IPF patients had lower TFEB and LC3B levels than controls, whilst activation of TFEB increases autophagic-flux after BLM treatment, inhibiting apoptosis and proliferation of epithelial cells, thus reducing fibrosis.47 The gene discussed is TFEB; the disease is idiopathic pulmonary fibrosis.